Paradromics

Paradromics implants first long-term brain chip in FDA speech-restoration study

Paradromics, an Austin-based neurotechnology company, has implanted its Connexus brain-computer interface in the first participant of its FDA-approved clinical study, marking a milestone in the company's nearly decade-long effort to restore speech for people with severe motor impairments.